Home/Filings/4/0001562180-19-003734
4//SEC Filing

COOKE MICHAEL P. 4

Accession 0001562180-19-003734

CIK 0001690585other

Filed

Jul 1, 8:00 PM ET

Accepted

Jul 2, 10:51 AM ET

Size

6.9 KB

Accession

0001562180-19-003734

Insider Transaction Report

Form 4
Period: 2019-07-01
COOKE MICHAEL P.
Chief Scientific Officer
Transactions
  • Sale

    common stock

    2019-07-01$14.39/sh5,000$71,933280,523 total
  • Sale

    common stock

    2019-07-01$14.42/sh2,500$36,051278,023 total
Footnotes (2)
  • [F1]This trade is pursuant to an active 10b5-1 plan.
  • [F2]This transaction was executed in multiple trades at prices ranging from $14.20 to $14.80. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request by the staff of the U.S. Securities and Exchange Commission, the issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected.

Issuer

Magenta Therapeutics, Inc.

CIK 0001690585

Entity typeother

Related Parties

1
  • filerCIK 0001741288

Filing Metadata

Form type
4
Filed
Jul 1, 8:00 PM ET
Accepted
Jul 2, 10:51 AM ET
Size
6.9 KB